158 related articles for article (PubMed ID: 32219144)
1. TRIM58 Interacts with Pyruvate Kinase M2 to Inhibit Tumorigenicity in Human Osteosarcoma Cells.
Yuan P; Zhou Y; Wang R; Chen S; Wang Q; Xu Z; Liu Y; Yang H
Biomed Res Int; 2020; 2020():8450606. PubMed ID: 32219144
[TBL] [Abstract][Full Text] [Related]
2. Tripartite Motif Containing 11 Interacts with DUSP6 to Promote the Growth of Human Osteosarcoma Cells through Regulating ERK1/2 Pathway.
Wang Z; Xu X; Tang W; Zhu Y; Hu J; Zhang X
Biomed Res Int; 2019; 2019():9612125. PubMed ID: 31950060
[TBL] [Abstract][Full Text] [Related]
3. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
Liu X; Long Z; Cai H; Yu S; Wu J
Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
[No Abstract] [Full Text] [Related]
4. TRIM32 Promotes the Growth of Gastric Cancer Cells through Enhancing AKT Activity and Glucose Transportation.
Wang J; Fang Y; Liu T
Biomed Res Int; 2020; 2020():4027627. PubMed ID: 32051827
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of pyruvate kinase type M2 suppresses tumor survival and invasion in osteosarcoma cells both in vitro and in vivo.
Yuan Q; Yu H; Chen J; Song X; Sun L
Exp Cell Res; 2018 Jan; 362(1):209-216. PubMed ID: 29155364
[TBL] [Abstract][Full Text] [Related]
6. TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway.
Sun N; Shen J; Shi Y; Liu B; Gao S; Chen Y; Sun J
World J Surg Oncol; 2023 Jul; 21(1):231. PubMed ID: 37516854
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.
Liu ZX; Hong L; Fang SQ; Tan GH; Huang PG; Zeng Z; Xia X; Wang XX
Tumour Biol; 2016 Nov; 37(11):14923-14928. PubMed ID: 27644251
[TBL] [Abstract][Full Text] [Related]
8. TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP.
Shang R; Chen J; Gao Y; Chen J; Han G
Dis Markers; 2023; 2023():5899662. PubMed ID: 36644609
[TBL] [Abstract][Full Text] [Related]
9. TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect.
Wu H; Guo X; Jiao Y; Wu Z; Lv Q
Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36196894
[TBL] [Abstract][Full Text] [Related]
10. LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis.
Pu F; Liu J; Jing D; Chen F; Huang X; Shi D; Wu W; Lin H; Zhao L; Zhang Z; Lv X; Wang B; Zhang Z; Shao Z
Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35244192
[TBL] [Abstract][Full Text] [Related]
11. Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.
Jiang W; Cai X; Xu T; Liu K; Yang D; Fan L; Li G; Yu X
Oncol Res; 2020 Sep; 28(4):409-421. PubMed ID: 32295675
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of TRIM58 expression is associated with a poor patient outcome and enhances colorectal cancer cell invasion.
Liu M; Zhang X; Cai J; Li Y; Luo Q; Wu H; Yang Z; Wang L; Chen D
Oncol Rep; 2018 Sep; 40(3):1251-1260. PubMed ID: 29956813
[TBL] [Abstract][Full Text] [Related]
13. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
14. Effects of PKM2 Gene Silencing on the Proliferation and Apoptosis of Colorectal Cancer LS-147T and SW620 Cells.
Ao R; Guan L; Wang Y; Wang JN
Cell Physiol Biochem; 2017; 42(5):1769-1778. PubMed ID: 28746922
[TBL] [Abstract][Full Text] [Related]
15. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
Li D; Yang J; Ma H; Sun C; Feng R
J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
[TBL] [Abstract][Full Text] [Related]
16. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.
Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z
Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
19. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
Yan XL; Zhang XB; Ao R; Guan L
J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
Qiu X; Huang Y; Zhou Y; Zheng F
Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]